Top Markets
Coin of the day
European Biotech Acquisition Corp. European Biotech Acquisition Corp.

European Biotech Acquisition Corp.

EBAC
Rank in Stocks #26984
European Biotech Acquisition Corp. (EBAC) is presently not engaged in... European Biotech Acquisition Corp. (EBAC) is presently not engaged in substantial business operations. Instead, its core purpose is to facilitate a business combination, potentially through a merger, share exchange, asset acquisition, share purchase, or reorganization, with one or more other companies or organizations. The firm was established in 2021 and its headquarters are located in Amsterdam, the Netherlands.
Share Price
$11.19
Last synced: 2023-03-02
Market Cap
$35.92M
Change (1 day)
-4.44%
Change (1 year)
0.00%
Country
NL
Trade European Biotech Acquisition Corp. (EBAC)
P/E ratio for European Biotech Acquisition Corp. (EBAC)
P/E ratio as of 2026 TTM: 0
According to European Biotech Acquisition Corp. latest financial reports and stock price the company's current price-to-earnings ratio (TTM) is 0. At the end of 2026 the company had a P/E ratio of 0.
P/E ratio history for European Biotech Acquisition Corp. from 2026 to 2026
P/E ratio at the end of each year
Year P/E Ratio Change
Not enough data for the provided dates.
P/E ratio for similar companies or competitors
How to read a P/E ratio?

The Price/Earnings ratio measures the relationship between a company's stock price and its earnings per share.
A low but positive P/E ratio stands for a company that is generating high earnings compared to its current valuation and might be undervalued. A company with a high negative (near 0) P/E ratio stands for a company that is generating heavy losses compared to its current valuation.

Companies with a P/E ratio over 30 or a negative one are generaly seen as "growth stocks" meaning that investors typically expect the company to grow or to become profitable in the future.

Companies with a positive P/E ratio bellow 10 are generally seen as "value stocks" meaning that the company is already very profitable and unlikely to strong growth in the future.